The automated, microfluidic-based antibiotic susceptibility testing (AST) system

Antibiotic Resistance of Bacteria

Antibiotic resistance is a pervasive issue and a serious threat to public health. Each use of antibiotics can lead to the development of resistance. Bacteria are increasingly becoming resistant to new antibiotics.

Every 15 minutes, someone in the world dies from an infection caused by antibiotic-resistant bacteria.

Every year, antibiotics save millions of lives and remain the primary treatment for life-threatening bacterial infections.
The excessive and improper prescription of antibiotics has led to a rise in antibiotic resistance, now a global healthcare challenge. Each year, 700,000 people die due to antibiotic resistance worldwide.
By 2050, it is estimated that antibiotic resistance could cause the deaths of 10 million people annually, potentially surpassing cancer as a leading cause of death.

Antibiotic Resistance is a Universal Challenge

50% of antibiotics used in hospitals are usually prescribed unnecessarily or improperly. While antibiotics are life-saving, each application can promote the development of antibiotic-resistant bacteria in humans. The battle against antibiotic resistance continues globally.

Bacteria are everywhere and spread easily

In settings like medical facilities, where natural bacterial clusters exist, bacteria transfer between patients and staff, often complicating treatment.

Bacteria spread between humans and animals in every environment and through every daily activity.

Bacterial infections can occur in any public space and via any mode of transport, both locally and internationally.

Bacteria are also present in all food.

Combating Bacteria Requires Accurate Diagnosis

Bacteria continually mutate, transferring resistance traits and rapidly becoming resistant to the effects of new antibiotics.

The optimal response is precise diagnostics

Antimicrobial Susceptibility Testing is effective solution to combat antibiotic resistance

BACTEROMIC is a diagnostic system designed to address one of the most critical challenges in modern medicine – multidrug resistance. The system enables phenotypic evaluation of the efficacy of antibiotics used in treating infections of the respiratory system, blood, urinary tract, and skin, among others. It also has the capability to detect resistance mechanisms. Thanks to the determination and expertise of a team of biotechnologists, engineers and software developers, and their innovative approach to modern diagnostics, this device has significant market potential and the potential to revolutionize antibiotic treatment.

Our mission

We develop and deliver the most advanced antimicrobial susceptibility testing system that revolutionizes bacterial infection treatment through speed and comprehensive information, while actively driving global awareness and commitment to combating antimicrobial resistance to improve every patients recovery worldwide.

Our vision